DalCor Pharmaceuticals
DalCor Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Montreal, Quebec, with offices in Zug, Switzerland, Leatherhead in the United Kingdom, and Sarasota, Florida. It is developing dalcetrapib, positioned as the first pharmacogenetic precision medicine in cardiovascular disease, targeted specifically at patients carrying the AA genotype at the rs1967309 variant of the ADCY9 gene — a genotype present in up to 20% of the general population and in more than 40% of populations of African ancestry. DalCor holds the worldwide exclusive license to develop, manufacture and commercialise dalcetrapib together with rights to the companion genetic marker. The compound is being evaluated in Dal-GenE-2 (DAL-302), a Phase 3 double-blind randomized placebo-controlled cardiovascular outcomes confirmatory trial in 2,000 post-acute-coronary-syndrome patients with the ADCY9 AA genotype, coordinated by the Montreal Health Innovations Coordinating Centre and following the dal-GenE (DAL-301) trial, which showed a 21% relative risk reduction in fatal and non-fatal myocardial infarction across 6,149 patients in 34 countries. DalCor runs no developer program and publishes no product API; the only machine-readable surface it exposes is the anonymously readable WordPress REST content API behind dalcorpharma.com, which serves the bilingual English/French corporate site.
DalCor Pharmaceuticals is listed with 1 API on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biotechnology, Cardiovascular, and Precision Medicine.
DalCor Pharmaceuticals’ developer surface includes support, authentication, and 23 more developer resources.
Kin Score
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
DalCor Pharmaceuticals Website (WordPress REST)
The public WordPress REST API (wp-json) of the DalCor Pharmaceuticals website at dalcorpharma.com: the route index of the site's content management system, catalogued as one sit...
Agent Skills 3
Packaged agent skills for driving this provider's APIs from an AI assistant.
Sync the DalCor English and French editions
AGENT SKILLAssemble a DalCor clinical programme brief
AGENT SKILLTrack DalCor press releases
AGENT SKILLOpenAPI Overlays 1
Overlays applied on top of this provider's contracts. Each card says who wrote it: a document the provider publishes, or one API Evangelist derived or generated.
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 3
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 3
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API
Other 6
Properties that don't map to a standard resource type
Source (apis.yml)
DalCor Pharmaceuticals API — frequently asked questions
Does DalCor Pharmaceuticals have an API?
Yes. APIs.io lists 1 API from DalCor Pharmaceuticals, including DalCor Pharmaceuticals Website (WordPress REST).
How do I authenticate with the DalCor Pharmaceuticals API?
DalCor Pharmaceuticals uses bearer-token authentication (http · 1 scheme). The details are profiled on APIs.io as Dalcor Pharmaceuticals Authentication.
Is the DalCor Pharmaceuticals API ready for AI agents?
DalCor Pharmaceuticals has a Kin Score of 15.0 out of 100 (emerging) and an Agent Readiness score of 6.3 (agent-aware), scored by API Evangelist on 2026-11-06.
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.